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Abstract
The investigation of vascular calcification and its underlying 
cellular and molecular pathways is of great interest in cur-
rent research efforts. Therefore, suitable assays are needed 
to allow examination of the complex calcification process 
under controlled conditions. The current study describes a 
new ex vivo model of isolated-perfused rat aortic tissue with 
subsequent quantification and vessel staining to analyze the 
calcium content of the aortic wall. A rat aorta was perfused 
ex vivo with control and calcification media for 14 days, re-
spectively. The calcification medium was luminally perfused 
and induced a significant increase in calcium deposition 
within the media of the vessel wall detected alongside the 
elastic laminae. Perfusion with control medium induced no 
calcification. In addition, the mRNA expression of the osteo-
genic marker bone morphogenetic protein 2 (BMP-2) in-
creased in aortic tissue after perfusion, while SM22α as 
smooth muscle marker decreased. This newly developed ex 
vivo model of isolated-perfused rat aorta is suitable for vas-
cular calcification studies testing inducers and inhibitors of 
vessel calcification and studying signaling pathways within 
calcification progression. © 2019 S. Karger AG, Basel
Introduction
Calcification of the vascular wall remains a major 
cause of morbidity and mortality in elderly patients as 
well as in patients with a high cardiovascular risk, e.g., 
those with end-stage renal disease [1]. However, a spe-
cific therapy treating vascular calcification is currently 
not available [1]. Considerable efforts within this research 
field have provided more insight into the pathogenesis, 
contributing factors, and associated cellular mechanisms 
[2–4].
Different experimental settings, i.e., in vitro assays us-
ing vascular smooth muscle cells (VSMC), ex vivo assays 
using aortic rings, and in vivo animal models mainly with 
rodents, have been established for studying the complex 
processes of vascular calcification. Each model differs in 
complexity and has assets and drawbacks. In vitro cell ex-
periments lack the complex environment of the vessel ar-
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chitecture. Ex vivo experiments with aortic rings lead to 
stimulation via both the internal and the external vessel 
surfaces. Therefore, it is not possible to distinguish be-
tween these variable influences on vascular calcification. 
In vivo models of different diseases in knockout or trans-
genic animals could help to identify the influence of one 
specific target molecule. For screening experiments and 
treatment studies, in vivo models are time-consuming, 
expensive, and associated with suffering of animals. 
Therefore, the development of a novel experimental ex 
vivo setting is necessary to simulate the vascular calcifica-
tion process by the perfusion technique exclusively via 
endoluminal stimulation.
This methodological paper describes a new ex vivo 
method of a rat isolated-perfused aorta (IPA) for 14 days 
under sterile humidified conditions at 37  ° C with subse-
quent analysis of vessel calcification by calcium quantifi-
cation and histological examination. In addition to a pro-
tocol description, results of induced vascular calcification 
are shown as proof of concept. These ex vivo model might 
bridge the experimental gap between the current avail-
able ex vivo and in vivo methods for vascular calcification 
experiments.
Materials and Methods
Materials
Buffer and cell culture media were purchased from Biochrom 
(Berlin, Germany). Salts and staining solutions were purchased 
from Carl Roth (Karlsruhe, Germany) and Sigma-Aldrich (Stein-
heim, Germany).
Animals
Animals were handled in accordance with the guidelines of di-
rective 2010/63/EU of the European Parliament on the protection 
of animals used for scientific purposes and the Animal Committee 
of Charité Berlin, Germany. Male Wistar rats were purchased from 
Janvier (Le-Genest-Sain-Isle, France). The animals were fed a nor-
mal chow diet with water ad libitum. They had a day-night cycle 
of 12 h in a humidified atmosphere. Prior to the experiments, there 
was at least 1 week for acclimatization. All of the animals were 
weighted to ensure accurate drug dosage calculation for anesthe-
sia. The rats used for the experiments were 2 months old (median 
age).
Experimental Setting
The perfusion chamber was designed and constructed special-
ly for the setting of aorta perfusion (Fig. 1). All individual chamber 
and tubing parts were autoclaved or used as sterile disposables. 
Assembly was done under sterile conditions.
The rat was narcotized with intraperitoneal injection of pento-
barbital (200 mg/kg body weight). After reaching surgical anesthe-
sia, the abdomen was opened and the abdominal aorta was subse-
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Fig. 1. Perfusion chamber scheme. a Perfusion chamber diagram. 
1: fixed module, 2: mobile module, 3: aortic clamping, 4: perfusion 
media tank, 5: pump, 6: aorta, 7: catheter, 8: movable part, and 
9: filter for gas exchange. The chamber is closed with a lid includ-
ing 4 filters for gas exchange. The chamber consists of stainless 
steel. All chamber and tubing parts are autoclavable or used as 
sterile disposables. b Snap of the chamber with 4 aortas between 
the fixed and mobile modules.
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quently freed mechanically from the surrounding adipose tissue. 
Next, the thoracic cavity was opened and the aorta was dissected 
along the desired length. The soft tissue surrounding the aorta was 
grasped with forceps and the aorta gradually liberated together 
with the adventitia by cutting in the cranial direction through the 
soft tissue and the branches with a generous safety distance. For 
aortic explantation, the aorta was proximally cut close to the aortic 
valve of the heart and distally directly beneath the renal arteries. 
The aorta was transferred to a cell culture dish with phosphate-
buffered saline. Peripheral fat tissue was carefully removed with 
micro scissors and forceps without impairment of aortic branches 
using a stereomicroscope. All outgoing vessels were cut and care-
fully closed using an electrocauter system (KLS Martin, Tuttlin-
gen, Germany) with bipolar forceps. The explanted aorta was cut 
beneath the left subclavian artery and above the celiac artery. The 
thoracic aortic part between these cuts was used for perfusion. For 
aorta clamping, catheter systems (14–16 gauge, without a needle) 
were used.
The buffer in the chamber surrounding the aorta is composed 
of sodium chloride (100 mmol/L), potassium chloride (5 mmol/L), 
magnesium chloride (0.5 mmol/L), sodium dihydrogenphosphate 
(0.5 mmol/L), glucose (10 mmol/L), and 1% antibiotics (penicillin/
streptomycin). The chamber was completely filled with buffer. For 
aortic perfusion a control medium (COM) and a calcification me-
dium (CAM) were used. The COM consisted of Dulbecco’s modi-
fied eagle media (4.5 g/L glucose) supplemented with 15% fetal calf 
sera and 1% penicillin/streptomycin. For the CAM, ascorbic acid 
(284 µmol/L) and sodium dihydrogenphosphate (5 mmol/L) were 
additionally added. In order to be able to compare the results ob-
tained under perfusion conditions with those of previous and on-
going studies, the same CAM as in the previous published investi-
gations was used [5, 6]. All buffers and media were used in sterile 
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Fig. 2. Quantification of calcification. a Comparison of initial calcium content (C0) and the content after perfu-
sion or incubation with COM. b Comparison of the calcium content in the proximal and distal aortic parts after 
perfusion and incubation with COM and CAM. n = 15, * p < 0.05, Mann-Whitney U test, two-tailed.
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conditions. The aorta was constantly perfused via a peristaltic 
pump with COM or CAM for 14 days by 37  ° C, 5% carbon dioxide, 
and humidity conditions of 95%. The perfusion media was changed 
4 times during the experiment. Simultaneously, up to 4 aortas were 
perfused with the same media per chamber experiment.
The chamber is closed with a lid. Gas exchange is facilitated to 
a sterile filter system. At the end of the perfusion experiment, the 
aorta was cut in proximal and distal subparts (Fig. 2) for further 
analysis (formalin conservation, cryoconservation, and decalcifi-
cation). A proximal part and a distal part of the aorta were cut into 
rings and incubated separately (ex vivo without perfusion) as the 
control.
Staining Methods
Aortic rings were fixed with buffered formalin (4%) for 24 h. 
Afterwards, they were dehydrated and embedded in paraffin. Aor-
tic slices (4 µm) were stained with hematoxylin/eosin (H/E) and 
Alizarin Red. Each sample was stained as serial cutting of at least 
3 aortic rings. Image acquisition and analysis were done using the 
AxioVert 200M System with Zen software (Zeiss, Jena, Germany).
Calcium Content
Aortic rings were decalcified with hydrochloric acid (0.6 
mol/L). The calcium content was measured in technical duplicates 
using a colorimetric Calcium C assay kit (ScienCell, Berlin, Ger-
many) according to the manufactures’ protocol. The calcium con-
tent was normalized to its tissue dry weight.
Gene Expression
RNA was extracted from the cryoconserved aortic ring for 
COM- and CAM-perfused aorta as well as from the incubation 
experiment. The RNA extraction was done using TrizolTM as per 
the manufacturer’s instructions. The amount and purity of RNA 
were determined by measuring the OD using a NanoDrop pho-
tometer (Thermo Fisher Scientific, Dreieich, Germany). RNA was 
reverse transcribed into cDNA using a High-Capacity cDNA Re-
verse Transcription KitTM (Thermo Fisher Scientific). The mRNA 
expression of the investigated proteins was determined by quanti-
tative real-time PCR using the CFX System with a SybrGreen kit 
(Bio-Rad, Munich, Germany). The oligonucleotide sequence is as 
follows: bone morphogenetic protein 2 (BMP-2) forward 5′-ACT 
TCC CGA CGC TTC TTC TTC A-3′, reverse 5′-GGC CAC TTC 
CAC CAC AAA CC-3′ [7], SM22α forward 5′-AGA GGG GCC 
TCA CAG GCT GG-3′, reverse 5′-ACA GCT GGG AAC AGG 
GGC CA-3′, GAPD forward 5′-AGA CAG CCG CAT CTT CTT 
GT-3′, reverse 5′-CTT GCC GTG GGT AGA GTC AT-3′. GAPD 
was ordered from Biozol (Eching, Germany) and all others were 
obtained from TibMolBiol (Berlin, Germany). Quantification of 
gene expression was normalized to GAPD as the house-keeping 
gene.
Statistical Analysis
Data are presented as means ± SEM (N represents the number 
of aortas from different animals). The experiments were done in at 
least 3 independent experiments with 1–4 aortas per approach. 
Statistical analyses were performed by using GraphPad Prism (ver-
sion 5) software. To evaluate differences between treatment 
groups, Anova and Mann-Whitney U tests were applied. p < 0.05 
was considered statistically significant.
Results and Discussion/Conclusion
This technical note describes a novel ex vivo rat aortic 
perfusion system for vascular calcification studies. The 
induction of vascular medial calcification by standard ex 
vivo incubation of aortic rings was compared with the 
novel IPA method. High-phosphate medium was used in 
both settings; however, while aortic rings in the standard 
ex vivo method are incubated in the medium, the aortic 
tube in the IPA method is constantly endoluminally per-
fused with it. Both settings were employed for 14 days and 
the calcium content was measured thereafter. Corre-
sponding aortic rings were decalcified directly after dis-
section (C0) and the calcium content was quantified as a 
control.
Calcification: Comparison of IPA Perfusion and  
ex vivo Incubation
As known from previous studies, in vitro and ex vivo 
calcification of VSMC could be induced by using medium 
with a high phosphate content [5, 6, 8]. Therefore, CAM 
containing a high phosphate concentration and COM 
containing a physiological phosphate concentration were 
used in the following experiments.
Due to putative differences between the properties of 
different aortic segments [4], the proximal and distal tho-
racic tissues were investigated independently using COM 
and CAM. Incubation (without perfusion) with CAM in-
duced a strong increase in calcium content (90- to 135-
fold) compared to incubation with COM in both investi-
gated aortic parts. Previous studies of ex vivo calcification 
(without perfusion) have shown similar results [6], with 
differences in calcium content due to different vascular 
beds used and variations in stimulation procedure and 
time [9]. Using IPA, perfusion with CAM induced a sig-
nificant increase in calcium content compared to perfu-
sion with COM of the proximal and distal aorta, respec-
tively (proximal: ∼5-fold, distal: ∼6-fold). Interestingly, 
the calcium content of CAM-perfused proximal and distal 
aortas was significantly lower compared with the CAM 
incubation procedure, whereas the effects of COM in both 
settings were comparable (Fig. 2b). The different exposure 
of VSMC to the high-phosphate medium might be one 
reason for the differences in calcium content. In the incu-
bation procedure of aortic rings, the tissue and cells are 
exposed from all sites to the medium. In contrast, perfu-
sion using the IPA method enables administration of the 
medium from the luminal site only. The endothelial bar-
rier might play a relevant role in the reduced calcification 
process. Concerning internal controls, there was no sig-
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nificant difference in calcium content observed between 
COM and C0 in the case of incubation and perfusion 
(Fig. 2a). Handling and the mere perfusion procedure did 
not induce calcification, because perfusion with COM did 
not significantly increase the aortic calcium content com-
pared to ex vivo incubation without perfusion.
In addition, the mRNA gene expression of osteogenic 
BMP-2 and SM22α, a smooth muscle marker, was mea-
sured in the aortic tissue to examine a phenotypic conver-
sion of VSMC upon CAM perfusion. The mRNA expres-
sion of BMP-2 was significantly elevated after aortic per-
fusion and incubation of CAM compared to the COM 
perfused/incubated aorta (Fig.  3a), while SM22α de-
creased (Fig. 3b). These results further suggest the induc-
tion of aortic mineralization upon CAM perfusion.
To obtain information about tissue integrity and the 
localization of calcification, aortic slices were stained with 
H/E for structural analysis and with Alizarin Red to con-
firm vessel calcification. For all investigated conditions, 
staining with H/E showed tissue integrity. In this study, 
neither necrotic lesions (e.g., lack of nucleus staining) nor 
homogenous cytoplasm colorability could be observed in 
histologic analysis. In control slides (C0) as well as within 
the slides after perfusion or incubation with COM, Aliza-
rin Red staining revealed no calcification within the vessel 
wall. In contrast, perfusion and incubation of the aortic 
tissue with CAM induced mineralization of the vessel 
wall (Fig. 4). 
IPA Compared to Other Known Calcification Studies
Currently, different cell culture models (ex vivo or in 
vivo) exist, with pros and cons. In vitro cell culture models 
using VSMC represent the easiest model to study calcifi-
cation. In this simplified experimental setting, inducers 
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Fig. 3. mRNA gene expression mRNA ex-
pression of BMP-2 (a) and SM22α (b) de-
tected by quantitative real-time PCR in 
aortic tissue after perfusion or incubation 
with CAM (black bar) or COM (white bar). 
n ≤ 5, * p < 0.05, Mann-Whitney U test, 
two-tailed.
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Fig. 4. Histological staining. H/E and Alizarin Red staining of representative images.
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and inhibitors could be investigated; the calcium content, 
the gene expression profile, and the enzyme activity could 
be used as readout. However, the physiological tissue or-
ganization of the cells is lost in culture. Therefore, pro-
cesses involving cooperative interaction with the extracel-
lular matrix cannot be investigated. Studying ex vivo ef-
fects using aortic rings partly overcomes this problem. 
Here, a primary calcification in the media alongside the 
elastic laminae can be induced [5, 6, 10, 11]. Nevertheless, 
it has to be considered, that the intima, the media, and the 
adventitia of the vessel wall are exposed to the test sub-
stances.
In vivo models represent a physiological but also the 
most complex experimental setting. Their advantage is 
that transgenic and knockout animals can be investigat-
ed. However, rodents are resistant to the development of 
medial calcification. For the induction of vascular calcifi-
cation, the homeostasis of the animal must be altered se-
verely, e.g., by the induction of chronic kidney disease, 
hyperparathyroidism, or hyperphosphatemia [12, 13], 
leading to an unpredictable alteration of signal pathways. 
Therefore, the transmission of results from these studies 
is limited.
The new ex vivo model of the IPA described here 
might fill this gap between ex vivo studies using aortic 
rings and in vivo animal models. With this new method, 
it is possible to investigate aortic tissue in a physiological 
manner via stimulation from the luminal site using per-
fusion for up to several weeks. In addition, it follows the 
3R principle [14] for reduction of the medical conditions 
and pain of laboratory animals. The experimental mod-
els already established are designed to perfuse an aorta 
for up to hours and for visualization of processes via mi-
croscopy [15–17]. The IPA is designed for long-term 
perfusion for up to several weeks, allowing the study of 
medial vascular calcification. The main advantage of the 
IPA model is that the substances being tested could be 
administered specifically from the luminal site and there-
fore in a more physiological manner. This might be one 
explanation for the lesser but putatively more physiolog-
ical calcification within the same time span compared to 
ex vivo incubation of aortic rings. A direct comparison 
of aortic calcium contents with in vivo models is difficult 
due to the complexity of and differences in the animal 
models. For example, vitamin D3-induced vascular calci-
fication results in an about 10-fold increase in calcium 
content [9], whereas induction of chronic kidney insuf-
ficiency results in an up to 100-fold increase in a rat mod-
el [18].
Study Limitations
There are some limitations of the current study. First, 
solely staining methods checked the tissue viability. In 
the future, cell viability and functional integrity especial-
ly of the endothelial barrier will be measured via small 
vessel myography before and after perfusion of the organ 
for 14 days. Second, only one perfusion duration was an-
alyzed. For better comparability to previous ex vivo ex-
periments, 14 days were chosen. Third, only aortas from 
2-month-old male rats were investigated. As known 
from the literature, age and sex may influence the extent 
of vascular calcification. In the framework of the proof-
of-concept study, defined conditions were chosen to as-
sess the effects on vascular calcification. In further stud-
ies, the gender-specific aspect of vascular calcification 
should be investigated with this new technique. Fourth, 
the wall shear stress induced by the aortic perfusion 
could not be measured directly. However, we measured 
the perfusion pressure using a transducer in preliminary 
experiments. Furthermore, a peristaltic perfusion mode 
was chosen with a defined mean perfusion pressure and 
frequency. Therefore, parameters determining the shear 
stress were standardized. Fifth, the current study inves-
tigated the effect of different perfusion media on vascular 
calcification in healthy rat aorta. The effects of different 
perfusion pressures and comorbidities, e.g., chronic kid-
ney disease, are highly interesting and will be investigat-
ed in further studies. Sixth, the perfusion of mouse aorta 
using this novel technique will broaden the experimental 
spectrum.
Novelty and Conclusion
The current study summarizes the experimental pro-
cedure and first proof-of-concept for vascular calcifica-
tion analysis in an ex vivo perfused aorta. For the first 
time, this model has enabled ex vivo perfusion of the aor-
ta, allowing studies with inducers/inhibitors of vessel 
calcification under controlled conditions via perfusion 
from the endoluminal site. A detailed analysis of the pro-
cesses of vascular calcification with histological and bio-
chemical methods could be performed after long-term 
aortic perfusion. It enables investigation of pharmaco-
logical drugs in calcification process and studying the 
role of the endothelium. Furthermore, this method could 
be used for other vascular beds of different species. More 
studies are needed regarding, e.g., different incubation 
times and determination of perfusion pressure before 
routine use.
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